Uriel Halbreich MD
Uriel Halbreich
MD
Professor and Director, BioBehavioral Research
Jacobs School of Medicine & Biomedical Sciences
Specialty/Research Focus
Behavioral pharmacology; Endocrinology; Endocrinology, Diabetes and Metabolism; Neurobiology; Psychiatry
Professional Summary:
My research is broadly concerned with studies of the biology of affective disorders and the development of biological markers and clinical laboratory tests for major depressive disorder. Hormonal modulation of brain and behavior with the emphasis on gonadal hormones and the hypothalamic-pituitary-adrenal system neurotransmitter and their metabolites.
Recent focus has been on Stress and Resilience and the comprehensive Interdisciplinary approach to Well-being. We collaborate with colleagues in over half a dozen countries under the aegis of the world Psychiatric association (WPA) Sections of Interdisciplinary Collaboration (I am the founding chair) and Urban Mental Health.
Research and Educational projects are pursued with 2 groups of Early-career Psychiatrists:At the WPA and the EPA, the emphasis is on development of Leadership and Managementskills.
Education and Training:
- Fellowship, Columbia University (1980)
- Hadassah University Hospital (1978)
- Tel Aviv University, Sakler Postgraduate Medical School (1978)
- Hadassah University Hospital (1976)
- Jerusalem Community Mental Health Center (1976)
- Kaplan Hospital, Outpatient Clinic (1976)
- Residency, Talbieh Psychiatric Hospital (1974)
- Certificate, Israeli Army (1969)
- MD, University Hadassah Medical School (1969)
- Internship, Medicine, Hadassah University Hospital (1968)
- University Hadassah Medical School (1961)
Employment:
- Teaching Professor of OB/GYN, OB/GYN, University of Pisa (2007-present)
- Consultant, Kaleida Healthcare Systems (1998-present)
- Research Professor of Ob/Gyn, State University of New York at Buffalo Jacobs School of Medicine & Biomedical Sciences (1988-present)
- Founder and Director of the Life Cycle Center, State University of New York at Buffalo (1987-present)
- Director of Bio-behavioral Research, State University of New York at Buffalo (1985-present)
- Professor of Psychiatry, State University of New York at Buffalo Jacobs School of Medicine & Biomedical Sciences (1985-present)
- Attending Physician, Erie County Medical Center (1985–2007)
- Executive Consultant, Harvard University Medical School (1998–2001)
- Visiting Professor, Harvard University Medical School (1996–1998)
- Consultant, Buffalo VA Medical Center (1985–1996)
- Founder and Director, SUNY/AB at Erie County Medical Center (1986–1993)
- Consultant, Buffalo Psychiatric Center (1987–1992)
- Founder and Director, Albert Einstein College of Medicine (1984–1985)
- Associate Professor of Psychiatry, Psychiatry, AECOM (1982–1985)
- Research Associate, Montefiore Hospital and Medical Center (1980–1985)
- Founder and Director, Albert Einstein College of Medicine (1982–1984)
- Assistant Professor of Psychiatry, Psychiatry, AECOM (1980–1982)
- Director, Albert Einstein College of Medicine (1980–1982)
- Assistant Professor of Clinical Psychiatry, Psychiatry, Columbia University College of Physicians and Surgeons (1978–1980)
- Research Psychiatrist, New York State Psychiatric Institute (1978–1980)
- Temporary Chief Physician, Hadassah University Hospital (1978)
- Chief Psychiatrist, Israeli Navy (Active Reserve) (1977–1978)
- Lecturer of Psychiatry, Psychiatry, Hebrew University Hadassah Medical School (1977–1978)
- First Assistant, Hadassah University Hospital (1976–1978)
- Lecturer, Bezalel Academy of Arts (1976–1978)
- Second Assistant, Kaplan Hospital (1974–1976)
- Vice Chief Medical Officer, Israeli Navy (1970–1972)
- Regiment Medical Officer, Israeli Army (1969–1970)
Awards and Honors:
- Article of the month--December 2021 (2021)
- America's Top Psychiatrist (2008)
- Honorary Fellow (2008)
- Service Award (2003)
- Citations in National and International Who's Who (1984)
- National Research Service Award (1980)
- Yon Gon Award (1978)
- Ben Gurion Award (1976)
Grants and Sponsored Research:
- January 2005–January 2008
A multicenter, randomized, double-blind, placebo- controlled study of the safety and efficacy of Arpiprazole as adjunctive therapy in the treatment of patients with major depressive disorder
Bristol Myers Squibb Co.
Role: Co-Investigator - January 2004–January 2008
Olanzapine vs. Aripiprazole in the treatment of acutely ill patients with schizophrenia
Eli Lilly and Company
Role: Co-Investigator - January 2002–January 2008
Identification and diagnosis of mental disorders in Beijing Ob/Gyn clinics
Pfizer Inc. Foundation
Role: Co-Investigator - January 2005–January 2007
A randomized, double-blind, placebo-controlled, parallel group study of the safety and efficacy of three dose levels of CORLUX (Mifepristone) plus an antidepressant vs. placebo plus and antidepressant in the treatment of psychotic symptoms in patients wi
Corcept
Role: Co-Investigator - January 2005–January 2007
Diagnosis of clinically relevant premenstrual syndromes- Achieving international interdisciplinary consensus for update of ICD-10 Diagnosis of PMS
Schering Inc.
Role: Co-Investigator - January 2002–January 2003
Phase III, open label, multicenter, multinational, contraceptive study of Medroxyprogesterone Acetate (MPA: mg) and Estradiol Cypionate (E2C 5 mg) injectable suspension administered subcutaneously
Pharmacia
Role: Co-Investigator - January 2001–January 2003
The Relationship between Valproate and Other Mood-Stabilizer Therapies to the Polycystic Ovarian Syndrome and Polycystic Ovarian Morphology in Women with Bipolar Disorder
Harvard Medical School
Role: Co-Investigator - January 1999–January 2003
A Comparative Study of the Steady-State Pharmacokinetics of Lithium Before and During Multiple Oral Daily Topiramate Dosing in patients with Bipolar Disorder
R.W. Johnson
Role: Co-Investigator - January 1999–January 2003
Beijing Double Blind Placebo Controlled Trial Comparing Fluoxetine to Electro-Acupuncture
Eli Lilly and Company
Role: Co-Investigator - January 2001–January 2002
Phase IIIB Multi center trial, a comparison of Lunelle and Depo-Provera on Bone Mineral Density
Pharmacia
Role: Co-Investigator - January 2001–January 2002
Systemic Treatment Enhancement Program for Bipolar Disorder
Role: Principal Investigator - January 2000–January 2002
A randomized, placebo-controlled, double blind study of Naltrel in promotion of abstinence among alcohol dependent subjects
Drug Abuse Science
Role: Co-Investigator - January 1999–January 2002
Systematic Treatment Enhancement Program for Bipolar Disorder
National Institute of Mental Health
Role: Principal Investigator - January 1999–January 2002
Risperidone Depot (Microspheres) in the treatment of Subjects with Schizophrenia and Schizoaffective Disorder
Janssen
Role: Co-Investigator - January 1998–January 2002
A double blind, randomized, placebo and historical controlled study of the safety and efficacy of premarin/trimegestrone for post menopausal hormone replacement therapy
Wyeth Ayerst Research
Role: Co-Investigator - January 1999–January 2001
Olanzapine Alone & in Combination with Fluoxetine vs. Placebo in Major Depressive Disorder with Psychotic Features
Eli Lilly and Company
Role: Co-Investigator - January 1999–January 2001
Study of St. John's Wart on Outpatients with DSM-IV Major Depression
Vanderbilt Research University
Role: Co-Investigator - January 1998–January 2001
Intermittent Dosing of Fluoxetine in the Treatment of Premenstrual Dysphoric Disorder: Late Luteal Phase Daily Dosing Versus Placebo
Eli Lilly and Company
Role: Co-Investigator - January 1999–January 2000
Open Label Reboxetine Rescue and Continuation Therapy
Pharmacia Upjohn
Role: Co-Investigator - January 1999–January 2000
Pharmacogenomics Blood Sampling Protocol
Pharmacia Upjohn
Role: Co-Investigator - January 1999–January 2000
Reboxetine vs. Placebo in the treatment of Major Depressive Disorder Resistant to Fluoxetine
Pharmacia Upjohn
Role: Co-Investigator - January 1998–January 2000
Olanzapine in the Reduction of Hyperprolactinemia
Eli Lilly and Company
Role: Co-Investigator - January 1996–January 2000
Double-Blinded Parallel Comparison of Luteal Phase Treatment with Sertraline and Placebo in Patients with Premenstrual Dysphoric Disorder
Pfizer, Inc.
Role: Co-Investigator - January 1997–January 1998
Reboxetine versus Placebo in the treatment of Major Depressive Disorder
Pharmacia Upjohn
Role: Co-Investigator - January 1996–January 1998
A Ten-Week, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Efficacy and Safety of Oral CP-93,393-1 in outpatients with Major Depressive Disorder
Role: Co-Investigator - January 1993–January 1997
Treatment of dysphoric menstrual syndromes with mifepristone (RU-486)
Rousel Uclaf
Role: Co-Investigator - January 1995–January 1996
Intermittent late luteal treatment with sertraline of women with dysphoric PMS-- A Pilot Study
Role: Co-Investigator - January 1995–January 1996
Fifty -two week, open label, randomized study evaluating the safety and efficacy of oral ziprasidone (CP-88-059-1) 40-80 mg, bid and risperidone (3-5 mg daily) in the maintenance treatment of outpatients with schizophrenia or schizo-affective disorder
Role: Co-Investigator - January 1994–January 1996
Sertraline (Placebo controlled, double blind) for treatment of women with dysphoric premenstrual syndrome
Pfizer Inc., U.S. Pharmaceutical Group
Role: Co-Investigator - September 1991–August 1995
Alpha 2 Receptors, Luteal Depression and Gonadal Hormones
National Institute of Mental Health
Role: Principal Investigator
$518,074 - June 1990–April 1994
Menstrually Related Changes in Cognitive Functions
National Institute of Mental Health
Role: Principal Investigator
$101,869 - January 1994–January 1994
Welbutrin sustained release form, as treatment for major depressive disorders
Burroughs Wellcome Co.
Role: Co-Investigator - January 1994–January 1994
Assessment of Mood and Cognition in Woman with Breast Cancer
Nathan Cummings Foundation
Role: Co-Investigator - January 1993–January 1994
Double blind follow-up comparison of sertraline, imipramine and placebo in patients with dysthymic disorder
Pfizer Inc., U.S. Pharmaceutical Group
Role: Co-Investigator - January 1992–January 1993
Double blind parallel comparison of sertraline, imipramine and placebo in outpatients with Dysthymia
Pfizer Inc., U.S. Pharmaceutical Group
Role: Co-Investigator - January 1992–January 1993
Luproid acetate depot for treatment of dysphoric PMS
TAP Pharmaceuticals, Inc.
Role: Co-Investigator - January 1991–January 1993
Estraderm patches as treatment of dysphoric PMS, an their influence on cognitive functions and the Imidazoline- CDS system
Ciba Geigi Co.
Role: Co-Investigator - January 1992–January 1992
Abecarnil (Placebo Controlled, low and high dose) for treatment of outpatients with Generalized Anxiety disorder
Sandoz Pharmaceuticals Corp.
Role: Co-Investigator - January 1991–January 1991
Drug Induced Osteoporosis and Behavioral Changes
Research for Health in Erie County
Role: Co-Investigator - January 1990–January 1991
Hormonal Modulation of Brain and Behavior
RGK Foundation
Role: Co-Investigator - January 1989–January 1990
Hormonal Modulation of Brain and Behavior
Daniel Roblins Memorial Fund
Role: Co-Investigator - January 1989–January 1989
The Use of Hydrochlorothiazide for Premenstrual Edema
Bristol Myers Squibb Co.
Role: Co-Investigator - January 1987–January 1989
Administrative Structure for Brain & Behavioral Research
National Institute of Mental Heath
Role: Principal Investigator - January 1985–January 1989
The Desipramine Cortisol Test in Depression
National Institute of Mental Health
Role: Co-Investigator - January 1987–January 1988
Clinical Study of Bupropion in Depression
Burroughs Wellcome Co.
Role: Co-Investigator - January 1985–January 1988
Biological Studies of Depression
SUNY- Biomedical Research
Role: Principal Investigator - January 1987–January 1987
Biology of Aberrant Behavior
Bernice P. Roger's Trust
Role: Co-Investigator - January 1985–January 1987
Cortisol, MHPG and Depression
National Institute of Mental Health
Role: Principal Investigator - January 1981–January 1986
Premenstrual Syndromes: Biological and Diagnostic
National Institute of Mental Health
Role: Co-Principal Investigator - January 1985–January 1985
Preliminary Studies of Tardive Dyskinesia
The Ritter's Foundation
Role: Co-Investigator - January 1982–January 1985
Cortisol Secretion and Depression: A New Test
National Institute of Mental Health
Role: Principal Investigator - January 1983–January 1984
The Prolactin Response to Reserpine in Schizophrenia
National Institute of Mental Health
Role: Co-Investigator - January 1983–January 1984
Biology of Affective Disorders and Schizophrenia
The Ritter's Foundation
Role: Co-Investigator - January 1982–January 1982
Biology of Affective Disorders and Premenstrual Changes
The Ritter's Foundation
Role: Co-Investigator - January 1982–January 1982
The Dean's Discretionary Fund
Richard Hirschfeld‘s Bequest
Role: Co-Investigator
$164,000 - January 1982–January 1982
Research in Biological Psychiatry
Richard Hirschfeld‘s Bequest
Role: Co-Investigator
$248,000 - January 1980–January 1981
Endocrinology of Mental Disorders
SUNY- Biomedical Research Grant
Role: Principal Investigator - January 2005
A multicenter, randomized, double-blind, placebo- controlled study of a combination of levonorgestrel and ethinyl estradiol in a continuous daily regimen in subjects with premenstrual dysphoric disorder
Wyeth Ayerst Research
Role: Co-Investigator - January 1994
2nd International Congress of Women's Mental Health
2nd International Congress of Women's Mental Health
Role: Co-Investigator
$811,170 - Prevalence of Hyperprolactinemia in Schizophrenic Patients Treated with Antipsychotic Drugs
Eli Lilly and Company
Role: Co-Investigator
Journal Articles:
- Halbreich U. (2021) Stress:a global Multidimentional common Denominator. British Journal of Psychiatry-Advances (May), 27(3): 142-144.
- Halbreich u. (2021) Stress-Related Physical and Mental Disorders: a New Paradigm. British Journal of Psychiatry-Advances (May), 27(3): 145-152.
- Halbreich U. (2021) Mental vaccines: Can resilience and adaptation of vulnerable individuals and populations be enhanced before disasters and crises?. British Journal of Psychiatry-advances (May), 27(3): 201-203.
- alam F.,Hossain R, Ahmed H, Alam M, Sarkar M, Halbreich U. (2021) Stressors and Mental Health in Bangladesh: Current situation and future hopes. British j of Psychiatry, International (Dec), 2021(12): 1-4.
- Halbreich U. (2021) Well-Being:Diversified perspectives in Search of Definitions. International J of Social Psychiatry (Dec), 2021(12): 1-4.
- Halbreich U. (2021) Metropolitan conglomerates in Developing countries: the Mumbai well-being challenge. Acta Scientific Neurology (Dec), 4(12): 45-46.
- Abi Zeid Daou, Halbreich U, Geller J. (2021) Impact of global and national crises on people with severe mental illness. British J Psychiatry-Advances (May), 27(3): 181-183.
- Singh A., Chatterjee U, MacDonald C. ,Repasky E., Halbreich U. (2021) Psychosocial stress and immunosuppression in cancer:what we can learn from new research?. British J of Psychiatry-Advances (May), 27(3): 187-197.
- Halbreich U. (2021) Culturally-biased Scientific reporting. Acta Scientific Neurology (Apr), 4(4): 13-14.
- Olangunju A, Bioku A,...Halbreich U. (2021) Psychological distress and sleep problems in healthcare workers in a developing context during COVID-19 pandemic; Implications for workplace well-being. Progress in Neurology-PsychoPharmacology and Biological Psychiatry (Apr), 110292(110): 1-5.
- Halbreich U. (2020) Impact of COVID-19 Pandemic on Academia. Acta Scientific Neurology (Nov), 3(11): 110-111.
- Halbreich U, Meng F. (2020) Mental Health of Healthcare Personnel during Quarantine for Infectious Epidemic--Real-time Data. Acta Scientific Neurology (May), 3(5): 24-30.
- Halbreich,U. Schultze T., Botbol M., Javed A et al. (2019) Partnerships for Interdisciplinary collaborativeGlobal Well-being. Asia-Pacific Psychiatry (Jul), 11(2): e12366.
- Freeman EW, Halbreich U, Grubb GS, Rapkin AJ, Skouby SO, Smith L, Mirkin S, Constantine GD. (2012) An overview of four studies of a continuous oral contraceptive (levonorgestrel 90 mcg/ethinyl estradiol 20 mcg) on premenstrual dysphoric disorder and premenstrual syndrome. Contraception (May), 85(5): 437-445.
- Halbreich U. (2010) Women's reproductive related disorders (RRDs). J Affect Disord (Apr), 122(1-2): 10-13.
- Halbreich U. (2010) Reports of my death from a brain cancer have not been evidence-based (at least so far). World Psychiatry (Feb), 9(1): 61-61.
- Song C, Halbreich U, Han C, Leonard BE, Luo H. (2009) Imbalance between pro- and anti-inflammatory cytokines, and between Th1 and Th2 cytokines in depressed patients: the effect of electroacupuncture or fluoxetine treatment. Pharmacopsychiatry (Sep), 42(5): 182-188.
- Halbreich U. (2009) Non-Western therapies for affective disorders: in pursuit of open-minded considerations of concepts and applications. CNS Spectr (May), 14(5): 243-246.
- Cascade E, Kalali AH, Halbreich U. (2008) Antidepressant prescribing by specialty and treatment of premenstrual dysphoric disorder. Psychiatry (Edgmont) (Dec), 5(12): 14-15.
- Halbreich U, Smail N, Tu X, Halbreich J. (2008) Participation in clinical trials may improve care of acute schizophrenia inpatients in a general hospital. CNS Spectr (Sep), 13(9): 757-761.
- Kayatekin ZE, Sabo AN, Halbreich U. (2008) Levetiracetam for treatment of premenstrual dysphoric disorder: a pilot, open-label study. Arch Womens Ment Health (Jul), 11(3): 207-211.
- Halbreich U. (2008) Selective serotonin reuptake inhibitors and initial oral contraceptives for the treatment of PMDD: effective but not enough. CNS Spectr (Jul), 13(7): 566-572.
- Halbreich U. (2008) Systematic reviews of clinical trials of acupuncture as treatment for depression: how systematic and accurate are they?. CNS Spectr (Apr), 13(4): 293-294.
- Alexander JL, Dennerstein L, Woods NF, McEwen BS, Halbreich U, Kotz K, Richardson G. (2007) Role of stressful life events and menopausal stage in wellbeing and health. Expert Rev Neurother (Nov), 7(11 Su): 93-113.
- Alexander JL, Dennerstein L, Dennerstein L, Woods NF, Halbreich U, Kotz K, Richardson G, Graziottin A, Sherman JJ. (2007) Arthralgias, bodily aches and pains and somatic complaints in midlife women: etiology, pathophysiology and differential diagnosis. Expert Rev Neurother (Nov), 7(11 Su): 15-26.
- Halbreich U, Kahn LS. (2007) Atypical depression, somatic depression and anxious depression in women: are they gender-preferred phenotypes?. J Affect Disord (Sep), 102(1-3): 245-258.
- Halbreich U, Alarcon RD, Calil H, Douki S, Gaszner P, Jadresic E, Jasovic-Gasic M, Kadri N, Kerr-Correa F, Patel V, Sarache X, Trivedi JK. (2007) Culturally-sensitive complaints of depressions and anxieties in women. J Affect Disord (Sep), 102(1-3): 159-176.
- Kadri N, Berrada S, Alami KHM, Manoudi F, Rachidi L, Maftouh S, Halbreich U. (2007) Mental health of Moroccan women, a sexual perspective. J Affect Disord (Sep), 102(1-3): 199-207.
- Jadresic E, Nguyen DN, Halbreich U. (2007) What does Chilean research tell us about postpartum depression (PPD)?. J Affect Disord (Sep), 102(1-3): 237-243.
- Douki S, Zineb SB, Nacef F, Halbreich U. (2007) Women's mental health in the Muslim world: cultural, religious, and social issues. J Affect Disord (Sep), 102(1-3): 177-189.
- Song Y, Zhou D, Fan J, Luo H, Halbreich U. (2007) Effects of electroacupuncture and fluoxetine on the density of GTP-binding-proteins in platelet membrane in patients with major depressive disorder. J Affect Disord (Mar), 98(3): 253-257.
- Halbreich U. (2007) Osteoporosis, schizophrenia and antipsychotics: the need for a comprehensive multifactorial evaluation. CNS Drugs (Jan), 21(8): 641-657.
- Halbreich U, Karkun S. (2006) Cross-cultural and social diversity of prevalence of postpartum depression and depressive symptoms. J Affect Disord (Apr), 91(2-3): 97-111.
- Halbreich JT, Halbreich U, Smail N. (2006) Screening of patients for clinical trials of premenstrual syndrome/premenstrual dysphoric disorder: methodological issues. Psychiatry Res (Mar), 141(3): 349-352.
- Halbreich U, O'Brien PM, Eriksson E, Bäckström T, Yonkers KA, Freeman EW. (2006) Are there differential symptom profiles that improve in response to different pharmacological treatments of premenstrual syndrome/premenstrual dysphoric disorder?. CNS Drugs (Jan), 20(7): 523-547.
- Halbreich U. (2005) The association between pregnancy processes, preterm delivery, low birth weight, and postpartum depressions--the need for interdisciplinary integration. Am J Obstet Gynecol (Oct), 193(4): 1312-1322.
- Feld J, Halbreich U, Karkun S. (2005) The association of perimenopausal mood disorders with other reproductive-related disorders. CNS Spectr (Jun), 10(6): 461-470.
- Rasgon N, Shelton S, Halbreich U. (2005) Perimenopausal mental disorders: epidemiology and phenomenology. CNS Spectr (Jun), 10(6): 471-478.
- Halbreich U. (2005) Algorithm for treatment of premenstrual syndromes (PMS): experts' recommendations and limitations. Gynecol Endocrinol (Jan), 20(1): 48-56.
- Halbreich U. (2004) The diagnosis of premenstrual syndromes and premenstrual dysphoric disorder--clinical procedures and research perspectives. Gynecol Endocrinol (Dec), 19(6): 320-334.
- Halbreich U, Kornstein SG. (2004) Mental symptoms and disorders during pregnancy. CNS Spectr (Mar), 9(3): 176-176.
- Halbreich U. (2004) Prevalence of mood symptoms and depressions during pregnancy: implications for clinical practice and research. CNS Spectr (Mar), 9(3): 177-184.
- Kahn LS, Halbreich U, Bloom MS, Bidani R, Rich E, Hershey CO. (2004) Screening for mental illness in primary care clinics. Int J Psychiatry Med (Jan), 34(4): 345-362.
- Halbreich U, Kahn LS. (2003) Treatment of premenstrual dysphoric disorder with luteal phase dosing of sertraline. Expert Opin Pharmacother (Nov), 4(11): 2065-2078.
- Halbreich U, Kahn L. (2003) Hyperprolactinemia in schizophrenia: mechanisms and clinical aspects. J Psychiatr Pract (Sep), 9(5): 344-353.
- Halbreich U, Kahn LS. (2003) Hyperprolactinemia and schizophrenia: mechanisms and clinical aspects. J Psychiatr Pract (Sep), 9(5): 344-353.
- Halbreich U. (2003) The etiology, biology, and evolving pathology of premenstrual syndromes. Psychoneuroendocrinology (Aug), 28 Su: 55-99.
- Halbreich U, Borenstein J, Pearlstein T, Kahn LS. (2003) The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD). Psychoneuroendocrinology (Aug), 28 Su: 1-23.
- Kinon BJ, Gilmore JA, Liu H, Halbreich UM, Halbreich U. (2003) Hyperprolactinemia in response to antipsychotic drugs: characterization across comparative clinical trials. Psychoneuroendocrinology (Apr), 28 Su: 69-82.
- Halbreich U, Kahn LS. (2003) Hormonal aspects of schizophrenias: an overview. Psychoneuroendocrinology (Apr), 28 Su: 1-16.
- Halbreich U, Kinon BJ, Gilmore JA, Kahn LS. (2003) Elevated prolactin levels in patients with schizophrenia: mechanisms and related adverse effects. Psychoneuroendocrinology (Jan), 28 Su: 53-67.
- Halbreich U. (2003) Anxiety disorders in women: a developmental and lifecycle perspective. Depress Anxiety (Jan), 17(3): 107-110.
- Abraham G, Halbreich U, Friedman RH, Josiassen RC. (2003) Bone mineral density and prolactin associations in patients with chronic schizophrenia. Schizophr Res (Jan), 59(1): 17-18.
- Tandon R, Halbreich U. (2003) The second-generation 'atypical' antipsychotics: similar improved efficacy but different neuroendocrine side effects. Psychoneuroendocrinology (Jan), 28 Su: 1-7.
- Halbreich U. (2002) The pathophysiologic background for current treatments of premenstrual syndromes. Curr Psychiatry Rep (Dec), 4(6): 429-434.
- Halbreich U, Bergeron R, Yonkers KA, Freeman E, Stout AL, Cohen L. (2002) Efficacy of intermittent, luteal phase sertraline treatment of premenstrual dysphoric disorder. Obstet Gynecol (Dec), 100(6): 1219-1229.
- Mitwally MF, Kahn LS, Halbreich U. (2002) Pharmacotherapy of premenstrual syndromes and premenstrual dysphoric disorder: current practices. Expert Opin Pharmacother (Nov), 3(11): 1577-1590.
- Kahn LS, Halbreich U. (2001) Oral contraceptives and mood. Expert Opin Pharmacother (Sep), 2(9): 1367-1382.
- Halbreich U, Kahn LS. (2001) Are women with premenstrual dysphoric disorder prone to osteoporosis?. Psychosom Med (May), 63(3): 361-364.
- Halbreich U, Kahn LS. (2001) Role of estrogen in the aetiology and treatment of mood disorders. CNS Drugs (Jan), 15(10): 797-817.
- Halbreich U, Kahn LS. (2000) Selective oestrogen receptor modulators--current and future brain and behaviour applications. Expert Opin Pharmacother (Dec), 1(7): 1385-1398.
- Piletz JE, Halbreich U. (2000) Imidazoline and alpha(2a)-adrenoceptor binding sites in postmenopausal women before and after estrogen replacement therapy. Biol Psychiatry (Nov), 48(9): 932-939.
- Pearlstein TB, Halbreich U, Batzar ED, Brown CS, Endicott J, Frank E, Freeman EW, Harrison WM, Haskett RF, Stout AL, Yonkers KA. (2000) Psychosocial functioning in women with premenstrual dysphoric disorder before and after treatment with sertraline or placebo. J Clin Psychiatry (Feb), 61(2): 101-109.
- Halbreich U. (1999) Premenstrual syndromes: closing the 20th century chapters. Curr Opin Obstet Gynecol (Jun), 11(3): 265-270.
- Kouri EM, Halbreich U. (1998) Effects of alcohol and other drugs in women of reproductive age: hormonal interactions. Drugs Today (Barc) (Oct), 34(10): 837-843.
- Kouri EM, Halbreich U. (1998) Hormonal treatments for premenstrual syndrome. Drugs Today (Barc) (Jul), 34(7): 603-610.
- Kouri EM, Halbreich U. (1998) Psychotropic effects of hormonal replacement therapy. Drugs Today (Barc) (Mar), 34(3): 251-257.
- Freeman EW, Halbreich U. (1998) Premenstrual syndromes. Psychopharmacol Bull (Jan), 34(3): 291-295.
- Halbreich U. (1998) Evaluation of women's mental health: delineation of the field, and needs and steps toward a consensus. Psychopharmacol Bull (Jan), 34(3): 247-249.
- Halbreich U. (1998) Future directions for studies of women's mental health. Psychopharmacol Bull (Jan), 34(3): 327-331.
- Halbreich U. (1997) Menstrually related disorders--towards interdisciplinary international diagnostic criteria. Cephalalgia (Dec), 17 Su: 1-4.
- Halbreich U, Smoller JW. (1997) Intermittent luteal phase sertraline treatment of dysphoric premenstrual syndrome. J Clin Psychiatry (Sep), 58(9): 399-402.
- Halbreich U. (1997) Role of estrogen in postmenopausal depression. Neurology (May), 48(5 Sup): 16-19.
- Halbreich U. (1997) Premenstrual dysphoric disorders: a diversified cluster of vulnerability traits to depression. Acta Psychiatr Scand (Mar), 95(3): 169-176.
- Shelton RC, Davidson J, Yonkers KA, Koran L, Thase ME, Pearlstein T, Halbreich U. (1997) The undertreatment of dysthymia. J Clin Psychiatry (Feb), 58(2): 59-65.
- Kouri EM, Halbreich U. (1997) State and trait serotonergic abnormalities in women with dysphoric premenstrual syndromes. Psychopharmacol Bull (Jan), 33(4): 767-770.
- Chakravorty SG, Halbreich U. (1997) The influence of estrogen on monoamine oxidase activity. Psychopharmacol Bull (Jan), 33(2): 229-233.
- Halbreich U. (1997) Hormonal interventions with psychopharmacological potential: an overview. Psychopharmacol Bull (Jan), 33(2): 281-286.
- Halbreich U, Petty F, Yonkers K, Kramer GL, Rush AJ, Bibi KW. (1996) Low plasma gamma-aminobutyric acid levels during the late luteal phase of women with premenstrual dysphoric disorder. Am J Psychiatry (May), 153(5): 718-720.
- Halbreich U, Shen J, Panaro V. (1996) Are chronic psychiatric patients at increased risk for developing breast cancer?. Am J Psychiatry (Apr), 153(4): 559-560.
- Halbreich U, Palter S. (1996) Accelerated osteoporosis in psychiatric patients: possible pathophysiological processes. Schizophr Bull (Jan), 22(3): 447-454.
- Halbreich U, Rojansky N, Palter S, Hreshchyshyn M, Kreeger J, Bakhai Y, Rosan R, Bakhai YD. (1995) Decreased bone mineral density in medicated psychiatric patients. Psychosom Med (Sep), 57(5): 485-491.
- Halbreich U, Rojansky N, Palter S, Tworek H, Hissin P, Wang K. (1995) Estrogen augments serotonergic activity in postmenopausal women. Biol Psychiatry (Apr), 37(7): 434-441.
- Halbreich U. (1995) Menstrually related disorders: what we do know, what we only believe that we know, and what we know that we do not know. Crit Rev Neurobiol (Jan), 9(2-3): 163-175.
- Halbreich U. (1994) Teaching normal and abnormal behavior to primary care physicians. Int J Psychiatry Med (Jan), 24(2): 115-120.
- Halbreich U, Piletz JE, Carson S, Halaris A, Rojansky N. (1993) Increased imidazoline and alpha 2 adrenergic binding in platelets of women with dysphoric premenstrual syndromes. Biol Psychiatry (Nov), 34(10): 676-686.
- Halbreich U, Lumley LA. (1993) The multiple interactional biological processes that might lead to depression and gender differences in its appearance. J Affect Disord (Oct), 29(2-3): 159-173.
- Halbreich U, Bancroft J, Dennerstein L, Endicott J, Faccinetti F, Genazzani A, Morse C, Parry B, Rubinow D, Reid R. (1993) Menstrually Related Disorders: points of consensus, debate, and disagreement. Neuropsychopharmacology (Aug), 9(1): 13-15.
- Golan D, Aharoni A, Halbreich U. (1993) Prolactin response to electroconvulsive shock in anesthetized rats. J Psychiatr Res (Jul), 27(3): 235-240.
- Halbreich U, Tworek H. (1993) Altered serotonergic activity in women with dysphoric premenstrual syndromes. Int J Psychiatry Med (Jan), 23(1): 1-27.
- Hamilton JA, Halbreich U. (1993) Special aspects of neuropsychiatric illness in women: with a focus on depression. Annu Rev Med (Jan), 44: 355-364.
- Halbreich U, Piletz J, Halaris A. (1992) Influence of gonadal hormones on neurotransmitters, receptor, cognition and mood. Clin Neuropharmacol (Jan), 15 Su: 590-591.
- Halbreich U, Rojansky N, Palter S. (1991) Elimination of ovulation and menstrual cyclicity (with danazol) improves dysphoric premenstrual syndromes. Fertil Steril (Dec), 56(6): 1066-1069.
- Rojansky N, Halbreich U. (1991) Prevalence and severity of premenstrual changes after tubal sterilization. J Reprod Med (Aug), 36(8): 551-555.
- Miller AH, Asnis GM, Lackner C, Halbreich U, Norin AJ. (1991) Depression, natural killer cell activity, and cortisol secretion. Biol Psychiatry (May), 29(9): 878-886.
- Halbreich U, Rojansky N, Zander KJ, Barkai A. (1991) Influence of age, sex and diurnal variability on imipramine receptor binding and serotonin uptake in platelets of normal subjects. J Psychiatr Res (Jan), 25(1-2): 7-18.
- Rojansky N, Halbreich U, Zander K, Barkai A, Goldstein S. (1991) Imipramine receptor binding and serotonin uptake in platelets of women with premenstrual changes. Gynecol Obstet Invest (Jan), 31(3): 146-152.
- Halbreich U, Rojansky N, Bakhai Y, Wang K, Bakhai YD. (1991) Menstrual irregularities associated with bupropion treatment. J Clin Psychiatry (Jan), 52(1): 15-16.
- Halbreich U. (1990) Treatment of premenstrual syndromes with progesterone antagonists (e.g., RU-486): political and methodological issues. Psychiatry (Nov), 53(4): 407-409.
- Halbreich U. (1990) Estrogen replacement in postmenopausal disorders. Biol Psychiatry (Sep), 28(5): 369-371.
- Halbreich U, Castaneda R, Galanter M, Mandola R, Sharpless N. (1990) Plasma MHPG and age in detoxified alcoholics. Biol Psychiatry (Mar), 27(6): 626-630.
- Halbreich U. (1990) Gonadal hormones and antihormones, serotonin and mood. Psychopharmacol Bull (Jan), 26(3): 291-295.
- Halbreich U, Lemus CZ, Lieberman JA, Parry B, Schiavi RC. (1990) Gonadal hormones, sex and behavior. Psychopharmacol Bull (Jan), 26(3): 297-301.
- Halbreich U, Castaneda R, Galanter M. (1989) Low basal levels of cortisol distinguish detoxified alcoholics with major depressive disorder from non-MDDs. Alcohol Clin Exp Res (Dec), 13(6): 834-836.
- Carson SW, Halbreich U, Yeh CM, Galanter M. (1989) Liver function, plasma dexamethasone, and DST results in detoxified alcoholics. Psychiatry Res (Nov), 30(2): 217-221.
- Halbreich U, Carson SW. (1989) Drug studies in women of childbearing age: ethical and methodological considerations. J Clin Psychopharmacol (Oct), 9(5): 328-333.
- Halbreich U, Bakhai Y, Bacon KB, Goldstein S, Asnis GM, Endicott J, Lesser J, Bakhai YD. (1989) The normalcy of self-proclaimed "normal volunteers". Am J Psychiatry (Aug), 146(8): 1052-1055.
- Olympia JL; Halbreich U; Carson S. (1989) Hypothalamo-Pituitary Adrenal Activity in Endogenously Depressed Post Traumatic Stress Disorder Patients. Psychoendocrinolgy (Jan), 14(5): 365-379.
- Halbreich U, Olympia J, Carson S, Glogowski J, Yeh CM, Axelrod S, Desu MM. (1989) Hypothalamo-pituitary-adrenal activity in endogenously depressed post-traumatic stress disorder patients. Psychoneuroendocrinology (Jan), 14(5): 365-370.
- Asnis GM, Friedman JM, Miller AH, Iqbal N, Lo ES, Cooper TB, Halbreich U, Lemus CZ, van Praag HM, Rubinson E. (1989) Plasma dexamethasone and cortisol levels in depressed outpatients. J Affect Disord (Jan), 16(1): 5-10.
- Stewart JW, Halbreich U. (1989) Plasma melatonin levels in depressed patients before and after treatment with antidepressant medication. Biol Psychiatry (Jan), 25(1): 33-38.
- Halbreich U, Bakhai Y, Bacon KB, Goldstein S, Endicott J, Lesser J, Bakhai YD. (1989) Screening and selection process for studies of menstrually-related changes. J Psychiatr Res (Jan), 23(1): 65-72.
- Endicott J, Halbreich U. (1988) Clinical significance of premenstrual dysphoric changes. J Clin Psychiatry (Dec), 49(12): 486-489.
- Carson SW, Halbreich U, Yeh CM, Asnis G, Goldstein S. (1988) Cortisol suppression per nanogram per milliliter of plasma dexamethasone in depressive and normal subjects. Biol Psychiatry (Sep), 24(5): 569-577.
- Carson SW, Halbreich U, Yeh CM, Goldstein S. (1988) Altered plasma dexamethasone and cortisol suppressibility in patients with panic disorders. Biol Psychiatry (May), 24(1): 56-62.
- Halbreich U, Alt IH, Paul L. (1988) Premenstrual changes. Impaired hormonal homeostasis. Endocrinol Metab Clin North Am (Mar), 17(1): 173-194.
- Goldstein S, Halbreich U, Asnis G, Endicott J, Alvir J. (1987) The hypothalamic-pituitary-adrenal system in panic disorder. Am J Psychiatry (Oct), 144(10): 1320-1323.
- Halbreich U, Sharpless N, Asnis GM, Endicott J, Goldstein S, Vital-Herne J, Eisenberg J, Zander K, Kang BJ, Shindledecker R. (1987) Afternoon continuous plasma levels of 3-methoxy-4-hydroxyphenylglycol and age. Distinctive biologic subgroups of endogenous depression?. Arch Gen Psychiatry (Sep), 44(9): 804-812.
- Lemus CZ, Asnis GM, Halbreich U, Harkavy Friedman JM, Van Praag HM, Rubinson E, Eisenberg J. (1987) Clinical variables and hypothalamic-pituitary-adrenal function in depression. The importance of mood reactivity. J Affect Disord (May), 12(3): 219-221.
- Carson SW, Halbreich U. (1987) Effect of treatment on plasma cortisol and dexamethasone. Biol Psychiatry (Feb), 22(2): 213-216.
- Halbreich U, Goldstein S, Sharpless N, Asnis G, Kang BJ, Ryan J. (1987) Diurnal rhythm of plasma MHPG in endogenous depression. Psychiatry Res (Jan), 20(1): 79-81.
- Asnis GM, Halbreich U, Ryan ND, Rabinowicz H, Puig-Antich J, Nelson B, Novacenko H, Friedman JH. (1987) The relationship of the dexamethasone suppression test (1 mg and 2 mg) to basal plasma cortisol levels in endogenous depression. Psychoneuroendocrinology (Jan), 12(4): 295-301.
- Halbreich U, Naor S, Asnis G, Gasparini F, Goldstein S, Vital-Herne J, Kang BJ. (1986) Decreased dexamethasone suppression in endogenously depressed patients with normal basal plasma levels of cortisol. Biol Psychiatry (Dec), 21(14): 1434-1437.
- Halbreich U, Endicott J, Goldstein S, Nee J. (1986) Premenstrual changes and changes in gonadal hormones. Acta Psychiatr Scand (Dec), 74(6): 576-586.
- Lemus CZ, Asnis GM, Eisenberg J, Halbreich U, van Praag HM, Zukin SR. (1986) Imipramine binding and cortisol in depression. Biol Psychiatry (Dec), 21(14): 1440-1441.
- Asnis GM, Halbreich U, Rabinowitz H, Puigh-Antich J, Ryan N, Novacenko H. (1986) The dexamethasone suppression test (1 mg and 2 mg) in major depression: illness versus recovery. J Clin Psychopharmacol (Oct), 6(5): 294-296.
- Zern MA, Halbreich U, Bacon K, Galanter M, Kang BJ, Gasparini F. (1986) Relationship between serum cortisol, liver function, and depression in detoxified alcoholics. Alcohol Clin Exp Res (Jun), 10(3): 320-322.
- Sharpless NS, Halbreich U, Feldfogel H. (1986) Determination of total 3-methoxy-4-hydroxyphenylglycol in plasma using reversed-phase liquid chromatography with electrochemical detection. J Chromatogr (Apr), 377: 101-109.
- Endicott J, Nee J, Cohen J, Halbreich U. (1986) Premenstrual changes: patterns and correlates of daily ratings. J Affect Disord (Mar), 10(2): 127-135.
- Asnis GM, Eisenberg J, Lemus CZ, Halbreich U. (1986) Dexamethasone suppression test in schizophrenia. A study and review. Neuropsychobiology (Jan), 15(3-4): 109-113.
- Asnis GM, Lemus CZ, Halbreich U. (1986) The desipramine cortisol test--a selective noradrenergic challenge (relationship to other cortisol tests in depressives and normals). Psychopharmacol Bull (Jan), 22(3): 571-578.
- Halbreich U, Endicott J, Lesser J. (1985) The clinical diagnosis and classification of premenstrual changes. Can J Psychiatry (Nov), 30(7): 489-497.
- Halbreich U, Goldstein S, Cooper T, Mathé AA. (1985) Different pattern of association of beta-endorphin and cortisol responses to dextroamphetamine in postmenopausal women and young men. Psychiatry Res (Sep), 16(1): 11-19.
- Halbreich U, Asnis GM, Shindledecker R, Zumoff B, Nathan RS. (1985) Cortisol secretion in endogenous depression. I. Basal plasma levels. Arch Gen Psychiatry (Sep), 42(9): 904-908.
- Halbreich U, Asnis GM, Shindledecker R, Zumoff B, Nathan RS. (1985) Cortisol secretion in endogenous depression. II. Time-related functions. Arch Gen Psychiatry (Sep), 42(9): 909-914.
- Halbreich U, Endicott J. (1985) Relationship of dysphoric premenstrual changes to depressive disorders. Acta Psychiatr Scand (Apr), 71(4): 331-338.
- Asnis GM, Halbreich U, Rabinovich H, Ryan ND, Sachar EJ, Nelson B, Puig-Antich J, Novacenko H. (1985) The cortisol response to desipramine in endogenous depressives and normal controls: preliminary findings. Psychiatry Res (Mar), 14(3): 225-233.
- Halbreich U. (1985) Hormones and depression--conceptual transitions. Psychopharmacol Bull (Jan), 21(3): 568-572.
- Halbreich U, Endicott J. (1985) Methodological issues in studies of premenstrual changes. Psychoneuroendocrinology (Jan), 10(1): 15-32.
- Halbreich U, Vital-Herne J, Goldstein S, Zander K. (1984) Sex differences in biological factors putatively related to depression. J Affect Disord (Dec), 7(3-4): 223-233.
- Halbreich U, Asnis GM, Zumoff B, Nathan RS, Shindledecker R. (1984) Effect of age and sex on cortisol secretion in depressives and normals. Psychiatry Res (Nov), 13(3): 221-229.
- Perumal AS, Halbreich U, Barkai AI. (1984) Modification of beta-adrenergic receptor binding in rat brain following thyroxine administration. Neurosci Lett (Jul), 48(2): 217-221.
- Halbreich U, Vital-Herne J, Goldstein S, Zander K. (1984) Can gender differences in prevalence of depression be attributed to biological differences?. Psychopharmacol Bull (Jan), 20(3): 472-474.
- Halbreich U, Asnis G, Goldstein S, Nathan RS, Zander K, Herne JV. (1984) Sex differences in response to psychopharmacological interventions in humans. Psychopharmacol Bull (Jan), 20(3): 526-530.
- Asnis GM, Halbreich U, Sachar EJ, Nathan RS, Ostrow LC, Novacenko H, Davis M, Endicott J, Puig-Antich J. (1983) Plasma cortisol secretion and REM period latency in adult endogenous depression. Am J Psychiatry (Jun), 140(6): 750-753.
- Halbreich U, Endicott J, Nee J. (1983) Premenstrual depressive changes. Value of differentiation. Arch Gen Psychiatry (May), 40(5): 535-542.
- Nathan RS, Sachar EJ, Ostrow L, Asnis GM, Halbreich U, Halpern F, Renzi NL, Slotnick V. (1983) A preliminary study of sex-related differences in prolactin responses to dopamine blockade and insulin hypoglycemia and in penfluridol plasma levels in schizophrenic patients. Psychopharmacology (Berl) (Jan), 80(1): 46-49.
- Asnis GM, Halbreich U, Sachar EJ, Nathan RS, Davies M, Novacenko H, Ostrow LC, Endicott J, Puig-Antich J. (1982) Relationship of dexamethasone (2 mg) and plasma cortisol hypersecretion in depressive illness: clinical and neuroendocrine parameters. Psychopharmacol Bull (Oct), 18(4): 122-126.
- Halbreich U, Zumoff B, Kream J, Fukushima DK. (1982) The mean 1300-1600 h plasma cortisol concentration as a diagnostic test for hypercortisolism. J Clin Endocrinol Metab (Jun), 54(6): 1262-1264.
- Halbreich U, Sachar EJ, Asnis GM, Quitkin F, Nathan RS, Halpern FS, Klein DF. (1982) Growth hormone response to dextroamphetamine in depressed patients and normal subjects. Arch Gen Psychiatry (Feb), 39(2): 189-192.
- Nathan RS, Sachar EJ, Tabrizi MA, Asnis GM, Halbreich U, Halpern FS. (1982) Diurnal hormonal responses to thyrotropin-releasing hormone in normal men. Psychoneuroendocrinology (Jan), 7(2-3): 235-238.
- Asnis GM, Halbreich U, Nathan RS, Ostrow L, Novacenko H, Endicott J, Sachar EJ. (1982) The dexamethasone suppression test in depressive illness: clinical correlates. Psychoneuroendocrinology (Jan), 7(4): 295-301.
- Halbreich U, Endicott J, Schacht S, Nee J. (1982) The diversity of premenstrual changes as reflected in the Premenstrual Assessment Form. Acta Psychiatr Scand (Jan), 65(1): 46-65.
- Nathan RS, Sachar EJ, Tabrizi MA, Halbreich U, Asnis GM, Halpern FS. (1981) Effect of metergoline on the diurnal prolactin responses to insulin-induced hypoglycemia in normal men. Psychoneuroendocrinology (Dec), 6(4): 365-368.
- Endicott J, Halbreich U, Schacht S, Nee J. (1981) Premenstrual changes and affective disorders. Psychosom Med (Dec), 43(6): 519-529.
- Sachar EJ, Halbreich U, Asnis GM, Nathan RS, Halpern FS, Ostrow L. (1981) Paradoxical cortisol responses to dextroamphetamine in endogenous depression. Arch Gen Psychiatry (Oct), 38(10): 1113-1117.
- Asnis GM, Sachar EJ, Halbreich U, Nathan RS, Ostrow L, Soloman M, Halpern FS. (1981) Endocrine responses to thyrotropin-releasing hormone in major depressive disorders. Psychiatry Res (Oct), 5(2): 205-215.
- Asnis GM, Sachar EJ, Halbreich U, Nathan RS, Ostrow L, Halpern FS. (1981) Cortisol secretion and dexamethasone response in depression. Am J Psychiatry (Sep), 138(9): 1218-1221.
- Halbreich U, Endicott J. (1981) Possible involvement of endorphin withdrawal or imbalance in specific premenstrual syndromes and postpartum depression. Med Hypotheses (Aug), 7(8): 1045-1058.
- Asnis GM, Sachar EJ, Halbreich U, Ostrow LC, Nathan RS, Halpern FS. (1981) The prolactin-stimulating potency of reserpine in man. Psychiatry Res (Aug), 5(1): 39-45.
- Nathan RS, Sachar EJ, Asnis GM, Halbreich U, Halpern FS. (1981) Relative insulin insensitivity and cortisol secretion in depressed patients. Psychiatry Res (Jun), 4(3): 291-300.
- Halbreich U, Asnis G, Ross D, Endicott J. (1981) Amphetamine-induced dysphoria in postmenopausal women. Br J Psychiatry (Jun), 138: 470-473.
- Asnis GM, Sachar EJ, Halbreich U, Nathan RS, Novacenko H, Ostrow LC. (1981) Cortisol secretion in relation to age in major depression. Psychosom Med (Jun), 43(3): 235-242.
- Halbreich U, Sachar EJ, Asnis GM, Nathan RS, Halpern FS. (1981) The prolactin response to intravenous dextroamphetamine in normal young men and postmenopausal women. Life Sci (May), 28(21): 2337-2342.
- Nathan RS, Sachar EJ, Ostrow L, Asnis GM, Halbreich U, Halpern FS. (1981) Failure of dopaminergic blockade to affect prolactin, growth hormone, and cortisol responses to insulin-induced hypoglycemia in schizophrenics. J Clin Endocrinol Metab (Apr), 52(4): 807-809.
- Halbreich U, Weinberg U, Stewart J, Klein DF, Weitzman ED, Quitkin FM. (1981) An inverse correlation between serum levels of desmethylimipramine and melatonin-like immunoreactivity in DMI-responsive depressives. Psychiatry Res (Feb), 4(1): 109-113.
- Halbreich U, Sachar EJ, Asnis GM, Nathan RS, Halpern FS. (1981) Diurnal cortisol responses to dextroamphetamine in normal subjects. Psychoneuroendocrinology (Jan), 6(3): 223-229.
- Halbreich U, Asnis GM, Halpern F, Tabrizi MA, Sachar EJ. (1980) Diurnal growth hormone responses to dextroamphetamine in normal young men and post-menopausal women. Psychoneuroendocrinology (Dec), 5(4): 339-344.
- Asnis GM, Nathan RS, Halbreich U, Halpern FS, Sachar EJ. (1980) Prolactin changes in major depressive disorders. Am J Psychiatry (Sep), 137(9): 1117-1118.
- Sachar EJ, Asnis G, Nathan RS, Halbreich U, Tabrizi MA, Halpern FS. (1980) Dextroamphetamine and cortisol in depression. Morning plasma cortisol levels suppressed. Arch Gen Psychiatry (Jul), 37(7): 755-757.
- Sachar EJ, Nathan RS, Asnis G, Halbreich U, Tabrizi MA, Halpern F. (1980) Neuroendocrine studies of major depressive disorder. Acta Psychiatr Scand Suppl (Jan), 280: 201-210.
- Halbreich U, Assael M, Driefus D. (1980) Premonition of death in painting. Confin Psychiatr (Jan), 23(2): 74-81.
- Halbreich U, Sachar EJ, Nathan RS, Asnis GM, Halpern FS. (1980) The effect of benztropine mesylate on the prolactin response to haloperidol. Psychopharmacology (Berl) (Jan), 72(1): 61-65.
- Halbreich U, Friendly D. (1980) The characteristics of tension-provoking composition and lines--as represented in Munch's paintings. Confin Psychiatr (Jan), 23(3): 187-192.
- Asnis GM, Nathan RS, Davies SO, Halbreich U. (1979) Tardive dyskinesia presenting as a psychosis. J Nerv Ment Dis (Dec), 167(12): 762-763.
- Halbreich U, Grunhaus L, Ben-David M. (1979) Twenty-four-hour rhythm of prolactin depressive patients. Arch Gen Psychiatry (Oct), 36(11): 1183-1186.
- Halbreich U. (1979) Influence of deaf-mute parents on the character of their offspring. Acta Psychiatr Scand (Feb), 59(2): 129-138.
- Halbreich U, Torbati D. (1978) Capillary fragility during air exposure of man to 1-5 ATA and after decompression. Aviat Space Environ Med (Nov), 49(11): 1295-1296.
- Halbreich U, Segal S, Chowers I. (1978) Day-to-day variations in serum levels of follicle-stimulating hormone and luteinizing hormone in homosexual males. Biol Psychiatry (Oct), 13(5): 541-549.
- Halbreich U, Assael M, Ben-David M. (1978) Prolactin secretion during and after Noveril infusions to depressive patients. Psychopharmacology (Berl) (Mar), 56(2): 167-171.
- Halbreich U, Ben-David M. (1978) [Prolactin secretion and mental activity]. Harefuah (Feb), 94(3-4): 140-144.
- Halbreich U. (1978) A nonverbal dialogue as a treatment of schizophrenic patients. Confin Psychiatr (Jan), 21(1-3): 58-67.
- Halbreich U, Assael M. (1978) Electroencephalogram with sphenoidal needles in sleepwalkers. Psychiatr Clin (Basel) (Jan), 11(4): 213-218.
- Halbreich U, Steiner JE. (1977) An interaction between hyperbaric pressure and taste in man. Arch Oral Biol (Jan), 22(4): 287-289.
- Halbreich U, Kas D. (1977) Variations in the Taylor MAS of women with pre-menstrual syndrome. J Psychosom Res (Jan), 21(5): 391-393.
- Halbreich U, Ben-David M, Assael M, Bornstein R. (1976) Serum-prolatic in women with premenstrual syndrome. Lancet (Sep), 2(7987): 654-656.
- Halbreich U, Assael M, Kauly N, Eliraz A. (1976) Rheumatic brain disease: a disease in its own right. J Nerv Ment Dis (Jul), 163(1): 24-28.
- Halbreich U. (1976) Obesity: some psychological and physiological considerations. Confin Psychiatr (Jan), 19(1): 46-56.
- Halbreich U, Assael M. (1976) Pictorial expression of ulcerative colitis. Confin Psychiatr (Jan), 19(1): 35-45.
- Halbreich U, Assael M. (1976) "Clubbing" -- a side-effect of long-term phenothiazines treatment. Confin Psychiatr (Jan), 19(2): 96-98.
- Halbreich U. (1975) [Editorial: Hormonal aspects of homosexuality]. Harefuah (Oct), 89(8): 380-381.
- Halbreich U. (1974) Tegretol dependency and diversion of the sense of taste. Isr Ann Psychiatr Relat Discip (Dec), 12(4): 328-332.
Books and Book Chapters:
- Halbreich U. (2021) Micro-migration. In: Oxford text book of Migration. Oxford University Press, 189-192.
Service Activities:
- Recommend needed research on SDoMH to be pursued and supported by the APA; Co-chair,American Psychiatric Assoc.(APA) sub-committee on Research on Psycho-Social Determinants of Mental Health (2021–2022)
- Coordinated, invited collaborators, edited and completed a collaboration of the royal College of Psychiatrists, UK and the World Psychiatric Association (WPA) which resulted in a Special issue of the British Journal of Psychiatry-Advances of which I served as the guest-Editor.; Guest Editor (2020–2021)
- Have been supervising two groups of early-Career Psychiatrists in development of Leadership skills. Under the aegis of the World Psychiatric association and the European Psychiatric Association.; supervisor (2020–2022)
- H&J Med Infor Consultants; President (2006–present)
- IN-CLINE RE&D; President (2006–present)
- Buffalo West Side and Buffalo East Side Task Forces; Member (2005–present)
- Admissions Committee; Member (2004–2006)
- International Society of Affective Disorders; Member (2004–2006)
- World Psychiatric Association Section on Affective Disorders; Co-Chair (2004–2005)
- Interdisciplinary Research Review Panel; Member (2004–present)
- Department of Ob/Gyn Research Committee; Member (2003–present)
- Faculty Senate; Member (2002–2004)
- World Innovation Foundation (2002)
- World Innovation Foundation (2002–present)
- American Psychiatric Association Committee on Research on psychiatric Treatements- 2006- Present (2002–present)
- International Society of PsychoNeuroEndocrinology; President (2002–present)
- International Association for Women‘s Mental Health (2001–2004)
- International Association for Women's Mental Health; President (2001–2004)
- Institutional Resources Committee; Member (2001–2002)
- International Association for Women's Mental Health; Member (2001–present)
- 2nd HBN Congress; Chairman (2000)
- Department of Psychiatry Steering Committee; Member (2000–present)
- International Society of PsychoNeuroEndocrinology; President (1999–2002)
- International Society of PsychoNeuroEndocrinology; President (1999–2002)
- American Psychiatric Society (1999)
- International Brain Research Organization; Member (1999–present)
- Executive Committee and Board of Directors Jewish Family Services; Member (1998–2005)
- American College of Physician Executives; Member (1998–2002)
- American College of Forensic Examiners (1998–2001)
- Health Science Institutional Review Board; Member (1998–2001)
- Department of Psychiatry Continuing Medical Education; Member (1998–present)
- World Psychiatric Association Section on Interdisciplinary Collaboration; Chairman (1997–present)
- World Psychiatric Association section on Interdisciplinary Collaboration; Chairman (1997–present)
- Department of Psychiatry Primary Care Initiative Committee; Member (1994)
- Hormones, Brain and Neuropsychopharmacology (HBN); President (1993–2005)
- 1st International Congress on Hormones, Brain and NeuroPsychoPharmacology; Chairman (1993)
- Department of Psychiatry Long-Term Strategy and Goals Committee; Member (1992–1994)
- Association of Medicine and Psychiatry; Member (1991–2000)
- Department of Psychiatry Research and Faculty Development Committee; Member (1991–1994)
- Department of Psychiatry Income Fund Reimbursement Committee; Member (1991–1994)
- International Affairs; Member (1991–1994)
- Faculty Development Committee; Member (1991–1993)
- Apppointment, Promotions,Tenure & Privileges; Member (1990–1994)
- XXI Congress of the International Society of PsychoNeuroEndocrinology; Chairman (1990)
- Collegium Internationale Neuropsychopharmacologicum Education Committee, 1989-1996, 2002- Present Co-Chair- Education Committee, 1994-1996 Awards and Fellowship Committee, 1998-2000; Member (1989–2002)
- Faculty Council; Member (1989–1992)
- Task Force for Psychiatric Clinical Services Medical Consortium Erie County; Member (1989–1990)
- Society of Neuroscience; Member (1988–2005)
- American Neuropsychiatric Society; Member (1988–2003)
- American Neuropsychiatric Society; Member (1988–2003)
- Department of Psychiatry Faculty Development Committee; Member (1988–1990)
- Research Committee; Member (1988–1990)
- Task Force for Ob/Gyn Clinical Services Medical Consortium Erie County; Member (1988–1989)
- American College of Psychiatrists Program Committee- 1991-1995 Scientific Program Committee- 1999-2002; Member (1987–2002)
- American Society for Psychosomatic Obstetrics and Gynecology; Member (1987–1994)
- Residency Researcher Committee; Chair (1987–1989)
- Faculty Council; Member (1986–1987)
- World Federation for Mental Health; Member (1986–present)
- American College of NeuroPsychopharmacology Education and Training Committee, 1985-1988 Program and Scientific Communication Committee, 1988-1991 CME Liaison, 1992-1993 Constitution and Rules Committee, 1994-1996 Chairman, Constitution and Rules Committee 1996; Member (1985–2000)
- Buswell Fellowship Committee; Member (1985–1998)
- Department of Psychiatry Steering Committee; Member (1985–1996)
- Department of Psychiatry Continuing Medical Education; Member (1985–1996)
- Department of Psychiatry Research Committee; Chair (1985–1993)
- Department of Psychiatry Appointments, Promotions, and Tenure Comittee; Member (1985–1990)
- American Psychiatric Association (1983–present)
- American Association for the Advancement of Science; Member (1982–2002)
- New York Academy of Science; Member (1982–2000)
- Society of Biological Psychiatry; Member (1982–1993)
- American Psycho-Pathology Association (1982–present)
- International Society of PsychoNeuroEndocrinology; Member (1982–present)
- The Endocrine Society; Member (1980–2005)
- American Federation for Clinical Research; Member (1980–1989)
- American Society of Psychopathology of Expression; Member (1980–1984)